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Abstract
Tumour-induced angiogenesis is one of the six hallmarks of cancer. The localized bal-
ance between supply and demand of nutrients and oxygen is disturbed when tumours are
formed resulting in tumours receiving less nutrients and oxygen. The hypoxic (lack of
oxygen) tumours trigger sprouting until the newly-created capillaries develop a network
of blood vessels (through angiogenesis) connecting the tumour to the rest of the cardio-
vascular system. This process is affected by an interplay between different cell types, the
mechanical stresses in the extracellular matrix (ECM), and the cell signalling networks.
Each newly-formed capillary, sprout, is made up of two parts, the tip cell and the stalk
cells, with the morphology of the newly-created cells highly dependent on the tip cells’
movements. In this thesis I developed one of the first phase-field models of angiogenesis
incorporating the mechanics of the phenomenon. In addition, it is the only model to make
a connection between the movement of the tip cell and the fracture of the extracellular
matrix. Furthermore, the model integrates the biochemical elements into the mechanical
progression of the tip.
The solver presented here uses a set of partial differential equations (PDEs) to model
different aspects of the phenomenon. This solver consists of three modules; biomechanical,
biochemical, and the vascular network module. The biomechanical module is a set of two
PDEs. They are the linear momentum balance equation and a phase-field equation for
handling the two phases, the endothelial cells (ECs) and the ECM. The constitutive model
used here is for anisotropic soft material for both the ECs and the ECM. Energy-based
criterion for soft material is used for the fracture of the ECM. Second-order phase-field
models are developed here and are discussed with a set of examples.
The second module, biochemical, is made of four advection-diffusion-reaction equations,
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each of which is responsible for the concentration of one of the elements involved in the
process namely: oxygen, TAF (tumour angiogenesis factor), MMP (matrix metallopro-
teinases), the ECM (extracellular matrix). The third module, vascular network, describes
the movement of the tip cells, possible branching, and anastomosis. Unlike the other mod-
ules this module does not have PDEs and instead uses a nonlinear equation solver and a
stochastic function to find the location of the tip cell in each step.
The results of this modelling approach conform with the results available from older
computational models and experimental models making this work the first model of tumour-
induced angiogenesis considering the formation of matrix pathways prior to the migration
of the endothelial cells.
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Chapter 1
Introduction
1.1 Importance and motivation
Cancer is the leading cause of death in Canada, accounting for more than thirty percent of
deaths in 2012. It is known that one out of every two Canadians is diagnosed with cancer
during his/her lifetime [8]. Although cancer is a complex phenomenon, it is stated that six
(or eight) hallmarks constitute every cancer case including angiogenesis that is investigated
here [9, 10]. Most of cancer research has focused on the biological and biochemical aspects
of cancer with little attention to its mechanical aspects. The final goal of this research is
to propose a new framework to model angiogenesis which improves the understanding of
the phenomenon. The hope is that this framework would help to study what alterations
can slow angiogenesis down.
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1.2 Problem statement
Tumour-induced angiogenesis is the process of formation of new blood vessels that connects
the tumour to the vascular network to supply them with nutrients and oxygen. It is a
multi-physics phenomenon that involves secretion of tumour angiogenesis factors (TAFs),
degradation and remodelling of the extracellular matrix (ECM), proliferation and directed
migration of the endothelial cells towards the tumour cells, branching, anastomosis and
formation of loops in the newly-created blood vessels, and finally flow of blood in the
vessels. The complete modelling of angiogenesis should take into account the fields of
biochemistry, fluid mechanics, and solid mechanics. In this research, a modular solver
is written with each of the modules relating to one aspect of angiogenesis. Researchers
have developed biochemical and fluid mechanical models in the past, but there are only a
handful of models considering the mechanical, biochemical, and biological aspects of the
phenomenon. The model proposed here considers all these aspects of angiogenesis thus it
is called a chemo-bio-mechanical model.
A modified crack phase-field modelling is applied in this research to model the solid
mechanical aspect of the phenomena. It uses a set of partial differential equations (PDEs)
to model the deformations and the phase transition. Phase transition shows the migra-
tion of endothelial cells in the extracellular matrix. The model also incorporates a set of
biochemical advection-diffusion-reaction PDEs to model the biochemical aspect of angio-
genesis.
The model presented in this research is the only in silico model for tumour-induced
angiogenesis which incorporates biochemical equations and biomechanical equations with
phase-field analysis which also considers fracture mechanics for the formation of pathways
in the extracellular matrix for endothelial cells migration.
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1.3 Arrangement of the thesis
The second chapter starts with the biological basis of angiogenesis and continues with
a literature review of the computational research done on angiogenesis. It then briefly
explains phase-field analysis and provides the work done in this field. The third chapter
explains the solver used in this research and then the biomechanical module which includes
the endothelial cell migration and the deformations and stresses. The biochemical aspect
and the remainder of the theoretical basis are all covered in the fourth chapter. Results
from several runs are presented and discussed in chapter five. The last chapter contains the
conclusion and mentions several theoretical enhancements to develop the model further.
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Chapter 2
Literature Review
Angiogenesis is the formation of a network of blood vessels from pre-existing vasculature
[11]. The phenomenon was first observed and described in 1794 by John Hunter. It seems
that Flint, JM first coined the term in 1900 while he was describing the vascularization
of the adrenal gland [12]. The other method for the formation of new blood vessels is
called vasculogenesis. However, it is different from angiogenesis because vasculogenesis is
the formation of a network of blood vessels from mesodermal cells in embryogenesis and
does not require pre-existing vasculature [13].
There are two main types of angiogenesis from a morphological point of view, namely
splitting and sprouting angiogenesis. Splitting (or intussusceptive) angiogenesis is the
splitting of an existing blood vessel into two blood vessels caused by external forces from
the tissue surrounding the blood vessel [14]. Sprouting angiogenesis, as the name suggests,
is the sprouting of a new blood vessel from an existing blood vessel because of an external
stimulus [15] (Figure 2.1). A number of phenomena can trigger angiogenesis in capillaries
such as tissue-repair, wound healing, female reproductive cycle, and tumour growth [16, 17].
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Initial blood vessel
Intussusceptive angiogenesis Sprouting angiogenesis
Figure 2.1: Different types of angiogenesis.
The focus of this research is the modelling of the tumour-induced angiogenesis which is a
sub-category of sprouting angiogenesis with the proteins secreted from a tumour being the
external stimulus for vessel formation [18].
In the first section of this chapter, a brief introduction to the capillaries and tumour-
induced angiogenesis is provided. Capillaries are both the pre-existing blood vessels and
the final products of angiogenesis. In the second section, a review of the related work con-
ducted in the area of modelling angiogenesis, including their types, components, strength,
and weakness are presented. The third section introduces phase-field modelling and its
advanced features for modelling angiogenesis.
2.1 Biological aspect of the work
2.1.1 Capillaries
Capillaries are the thinnest and most abundant of the blood vessels which connect the
arterioles and venules. The blood flow starts from the heart, the blood full of oxygen
5
and nutrients goes to aorta, from aorta to arteries, arterioles, capillaries, venules, veins,
venae cavae, and from there back to the heart [19]. If the aorta, arteries, veins, and venae
cavae are the highways and main streets in the oxygen and nutrient delivery system, the
capillaries are the alleys of the system bringing the nutrients to the doorsteps of the tissues
and cells. Also, diffusion is how the nutrients and oxygen reach every cell in the body.
Unlike other blood vessels in the human body, the capillaries do not have a lot of
structural components such as smooth muscles; they are only made of endothelial cells,
basement membrane, and pericytes. The newly formed capillaries in sprouting angiogenesis
are mostly made up of endothelial cells, and as the vessels mature, the other two parts are
formed in the vessels’ walls [19]. Figure 2.2 shows the cross-section of a capillary where
endothelial cells line the inner wall of capillaries.
2.1.2 Tumour-induced angiogenesis
Cancer cells are products of several mutations resulting in changes in DNA sequences. One
of the significant differences between a cancer cell and a healthy cell is the difference in
the rate of cell proliferation and apoptosis; the processes of increasing and decreasing the
lumen basement
membrane
pericyte
endothilial cell
Figure 2.2: A capillary vessel cross section.
6
number of cells, respectively. Proliferation and apoptosis have a balance in healthy cells, so
the total number of cells stays constant in adults; in a phenomenon known as homeostasis
[20, 21]. This is not the case in cancer cells, the mutations increase the proliferation rate
and decrease the apoptosis rate so the tumour will grow compared to the surrounding
tissues [9, 22]. The vasculature in the body is designed to be sufficient for our bodies in
typical situations. When a tumour grows in the human body, the distance of some of the
tumour cells from the blood vessels becomes more than the penetration depth; the depth
that oxygen and nutrients can diffuse in the extracellular matrix (ECM) [23, 24]. This
would generally happen when the tumour diameter exceeds 2 to 3mm [25]. The cells in
the middle of a tumour now lack oxygen and nutrients causing them to become hypoxic
[26]. Hypoxia is dangerous to both healthy and cancer cells but as explained below, the
malignant cells have a way to overcome this lack of resources [27].
The tumour stops growing because of this lack, and the hypoxic cells start excreting
proteins called tumour angiogenesis factors (TAF) [28]. Most significant sub-group of
TAF proteins are named vascular endothelial growth factor (VEGF) [29]. These proteins
will spread in the tumour’s surrounding causing a concentration gradient of TAF towards
the tumour. The receptors on the endothelial cells will recognize these proteins, and the
endothelial cells will start moving towards the TAF’s gradient [30]. This process of cells
moving towards a higher concentration of soluble molecules is called chemotaxis [31]. Cell
migration results in sprouting and the movement of the sprout towards the tumour. The
sprout consists of two main parts; tip cell and stalk cells. The tip cell is the cell moving
because of chemotaxis, haptotaxis1, etc. while the stalk cells are the ones following the
1Haptotaxis is the directional movement of cells towards the higher values of cellular adhesion in the
ECM [32]. The term haptotaxis was first coined in 1967 by Carter [33]. Fibronectin present in the ECM
causes haptotaxis in angiogenesis [34]. At first, it was thought chemotaxis is a subset of haptotaxis but
7
Figure 2.3: Sprouting angiogenesis progress: a) Oxygen and nutrients not reaching the
deep cells in tumour resulting in hypoxia. b) Hypoxic cancer cells secreting TAF creating
a TAF concentration towards the tumour. c) Tip cells start moving toward the higher
gradient, the tumour, called chemotaxis. d) Stalk cells following the tip cell because of cell
adhesion. e) Formation of two sprouts from one. The sprouts finally reach the tumour cell
and the tumour starts to grow again.
tip cell because of the cell adhesion forces [37]. The VEGF molecules also increase the
proliferation rate in the endothelial cells providing the needed cells for sprout elongation
[31]. One other significant effect of VEGF on the sprouts is that it causes the tip cell
to excrete enzymes with the name of matrix metalloproteinase (MMP). These enzymes
will degrade the surrounding ECM and would eventually help the tip cell to penetrate
through it [38, 39, 40]. Different sprouts might merge into one. This phenomenon is called
anastomosis. Anastomosis results in loop formation and blood flow in the loops. Also, one
sprout can branch into two sprouts called branching.
When the sprouts reach the tumour, and a whole network of new blood vessels is con-
structed, blood would start flowing, and hence the tumour will receive its needed nutrients
later on this hypothesis was rejected [35]. For more information on haptotaxis, please refer to [36].
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and oxygen allowing the tumour to resume its growth. All angiogenesis processes can be
seen in Figure 2.3.
There is another important feature of angiogenesis not discussed above, and that is
ECM remodelling [19]. Before the movement of the endothelial cells in the extracellular
matrix, traction forces exerted by the ECs align the collagen fibres in the ECM along the
cell migration path [41].
2.2 Previous models of angiogenesis
There are three main approaches to model angiogenesis in cancer; continuous, discrete,
and hybrid [42]. Continuum modelling is the oldest of them and is the framework used in
this research. All three approaches are merely constructed by solving a system of partial
differential equations (PDEs). One of the earliest works done using the continuous method
is the paper by Zawicki in 1981 [43]. The first models were mostly one-dimensional models
not covering the morphological aspects of angiogenesis like branching or anastomosis [16].
They were mostly a system of two PDEs, one for the density of endothelial cells and the
other for the concentration of the chemical stimulus (TAF) for cell migration.
The first comprehensive in-silico model of tumour-induced angiogenesis was introduced
by Anderson in 1998 [30]. This model incorporated a system of three PDEs; one for EC
density, one for the concentration of TAF, and the last for fibronectin (FN) concentration.
The model proposed both continuous and discrete approaches for solving the system of
PDEs. The continuous model only showed the average density of the endothelial cells
and could not show the visual illustration of the network of the vessels created by angio-
genesis. However, the discrete approach succeeded in showing the morphological aspect
of angiogenesis and added three simple algorithms to account for branching, anastomosis,
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and EC proliferation. The discrete approach was widely used in recent literature. The con-
tinuous framework we are using in this research incorporates the Ginzburg-Landau type
equations for phase-field modelling to implement both the continuum approach and the
morphological properties of angiogenesis. More on our approach will be discussed later.
Newer models added more PDEs to account for other aspects of angiogenesis like the
evolution of MMP level, the ECM degradation by MMP [38], and the effect of the ECM’s
oxygen level on angiogenesis. However, all the models discussed to this point are purely
biochemical models not accounting for other aspects of tumour-induced angiogenesis like
fluids and solid mechanics. As mentioned before, anastomosis leads to loop formation
and flow of blood in the loops. The blood pressure increases the blood vessel diameter,
and flow of blood brings oxygen and nutrients to the tumour. The first models that also
covered the blood flow in the newly created capillaries during angiogenesis were presented
by McDougall [44, 26] where blood flow in the capillaries was modelled using a Poiseuille-
like expression with a nonlinear viscosity. In these models, the effect of the fluid mechanics
module on the model was limited to initiating new branches.
Migrating cells need to exert traction forces on the ECM to be able to move in a
multi-step process of cell migration. First, the cell senses the stimuli for movement using
the filopodia. Second, the cell extends and forms protruding lamellipodia. It attaches
the protruded parts to the ECM. Then, the cell contracts using its radial fibres. These
radial fibres are connected to finger-like structures on the cell wall holding the cell to the
ECM. It later tears the fibres in the back apart allowing the cell to move forward. To
model this sophisticated phenomena, it is essential to include a biomechanical engine in
our angiogenesis model [45]. One of the earliest attempts to model the interaction between
a cell and the ECM mathematically was presented by Murray in 1984 [46]. Also, the
interaction between the two in cell movement in angiogenesis was modelled by Manoussaki
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in 1996 [47] and Holmes in 2000 [48]. These papers assumed viscoelastic material properties
using Kelvin-Voigt model which is represented by a parallel system of a linear elastic spring
and a dashpot [49, 50]. The mechanical stresses affect both the path and the speed of
angiogenesis.
There is another way to model the migration of the tip cell in angiogenesis. This
approach uses empirical formulas for the speed of the tip cell which is related to the other
parameters, like the concentration of chemotactic and haptotactic stimuli or maximum
stress, which are calculated using the other PDEs. For further discussion on this approach
refer to [1, 5].
2.3 Phase-field modelling of crack propagation
The phase-field method is a method to solve non-equilibrium systems problems by con-
verting the discontinuous interfaces into continuous functions. Used primary in material
science and physics community, the framework was used in solving the problems with a
moving phase boundary [51]. Researchers studied the motion of phase boundaries since
the early 1800s. The problem was first solved in the 1890s by Josef Stefan [52]. At first,
the sharp interfaces were used for the movement of the boundary as seen in the green plot
shown in Figure 2.4; more on the figure in the next chapter. Unlike the second (red) and
fourth-order (blue) plots shown in the figure, these discontinuities were hard to implement.
Therefore to make it solvable using partial differential equations, some phase-field param-
eters, such as d, were assigned to the domain. The phase-field parameter can have two
types; conserved or non-conserved. For the conserved phase-field variables, Cahn-Hilliard
[53] equation is used to describe the evolution of the variable (Eq. 2.1), and for non-
conserved, Allen-Cahn [54] equation (Eq. 2.2) or the time-dependent Ginzburg-Landau
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Figure 2.4: Three different plots for the phase transition, the phase field parameter, d, is
defined to be between zero and one, where zero means that the point in the domain purely
consists of the extracellular matrix and one suggests that the point is occupied entirely
with endothelial cells. In the phase-field analysis, instead of the discontinuous transition
between the two phases, a continuous function is assumed, the red one is called a second-
order phase-field function and is a continuous function but not differentiable at the point
x=0, the blue one is a fourth-order function and is a differentiable function throughout the
domain. In all the plots l = 1 is assumed.
type equation is used.
In equations
∂ci
∂t
= ∇Mij∇ δF
δcj(r, t)
(2.1)
and
∂ηp
∂t
= −Lp∇ δF
δηp(r, t)
(2.2)
r is the location and t is the time, F is the free energy level of the system, cn and ηp are the
conserved and non-conserved field variables, Mi and Lp are the diffusivity and the mobility
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coefficients respectively [55].
A method similar to the one used in fracture modelling is applied to have two phases
in this research. Early work conducted by Griffith [56] and Irwin [57] proposed the base
theories and fundamentals of brittle fracture. However, Franc and Margio [58] made the
first attempts to model brittle fracture using phase-field method and energy minimization
in 1998 that was faced with the challenge of thermodynamic stability issue. A decade later,
Miehe proposed a method for brittle fracture modelling which was also thermodynamically
stable [2, 59]. Many shortcomings in Griffith’s method for crack modelling are addressed
in the proposed phase-field models. Recently, Rania and Miehe proposed a phase-field
method to model fracture in biological tissues [60]. Further improvements was made by
Gu¨ltekin [3, 61] to model highly anisotropic material using constitutive models proposed
by Holzapfel and Gasser [62, 63].
To the author’s knowledge, there is limited research effort that applied continuous
mechanical phase-field modelling approach for angiogenesis [51]. The main deficiency of
these models are the linear elastic material assumption, no network formation, and limited
biochemical integration. All the problems above will be addressed in our new model plus
a feature not present in any other papers on angiogenesis. The modelling of the ECM
remodelling and formation of matrix pathways using the equations of failure and crack
propagation in soft materials prior to the ECs penetrating in the ECM.
2.4 Conclusion
Few attempts have been made to develop a biomechanical model of the angiogenesis. Most
of the attention has been paid to the biochemical aspect of angiogenesis. There are semi-
discrete/semi-continuous phase-field models for modelling angiogenesis, but those models
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do not incorporate the mechanical aspects of the phenomenon [64]. However, the inte-
gration of these two, biomechanical and biochemical, has a great potential to realistically
model the process of angiogenesis which can result in a better understanding of the phe-
nomenon and later, this new mechanical oriented view on cancer can help creation of new
treatments for cancer.
Therefore, the proposed model in this research utilizes a modified fracture phase-field
modelling approach for modelling the matrix pathways in the extracellular matrix coupled
with a system of PDEs to account for a wide range of biochemical reactions in angiogenesis.
It also incorporates some advanced features to model the capillary formation. All are
discussed in the next chapter and chapter four.
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Chapter 3
Biomechanical Module
This chapter first discusses the big picture of the solver used in this research. It then
presents the biomechanical aspect of the solver, the base formulas, their derivation, and
the numerical implementation.
3.1 Solver components
The solver used in modelling of angiogenesis consists of three modules to solve three phys-
ical aspect of angiogenesis. They are the biomechanical, the biochemical, and the vascular
network module as shown in figure 3.1A. As illustrated in the figure, the solver starts with
the biochemical module, it calculates the values for the four biochemical variables, the
concentration of oxygen, TAF, and matrix degrading enzymes (MDE), and the density of
the ECM, in each time step. Then, these values are incorporated into the biomechanical
module which calculates the values for deformations, stresses, and phase change. This
module solves a nonlinear system of PDEs which requires nonlinear finite elements to be
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implemented using the Newton-Raphson method for each time step. This requires a set of
iterations in each time step for the biomechanical module. One iteration is shown in Figure
3.1B. After the second module execution, the results are passed to the third module, the
vascular network module. This module checks if there is a need for updating the location
of the tip cell and if so, it uses the Newton-Raphson method to find the location of the next
tip cell. The module then checks for branching and anastomosis and starts the biochemical
module for the next time step. The analysis is complete when the newly-constructed blood
vessel reaches the tumour.
In the next sections of the chapter, we will address the formulas and their derivations
in the biomechanical module.
3.2 The biomechanical module
This module is the most comprehensive module in the analysis and takes most of the run-
time for the solver. It uses the large deformation, soft material properties, and anisotropic
formulas mainly derived from Bower [65] and Holzapfel and Gasser [63, 62]. This module
consists of two main PDEs in the Lagrange-Euler equations format. One of them is the
equation governing the balance of linear momentum, and the other one is the equation
determining the topology of the diffusive phase transfer.
As seen in Figure 3.1B, this module consists of three steps in each iteration, the first step
solves the balance of linear momentum PDE and outputs the values for deformations, the
second step calculates the values for the history function which is the connection between
the two PDEs. The last step uses the values of the history function to solve the phase
transfer PDE. The loop would run until the convergence criterion is met.
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Figure 3.1: The flow diagram representing the different modules in the solver. A: The three
main modules building up the solver. The solver starts with the biochemical module (mod-
ule I) that calculates the concentration of oxygen and MDE in the domain and implements
their values to calculate the TAF level and the density of the ECM respectively. Module I
feeds the values of concentrations to the biomechanical module (module II). This module
calculates the deformation, the stresses, and the phase movement as shown in B. Vascular
network module (module III) updates the tip cell location and checks for branching and
anastomosis. After the third module’s execution, the solver proceeds to the next time step.
B: This figure is the flow diagram of the second module. At first, the continuum mechanics
sub-module is run to find the deformations and the stresses throughout the domain. Then
the history function is executed in all Gaussian points to find in which, the phase transition
has started. Then the phase-field PDE is solved to calculate the movement of EC in the
ECM.
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Fφ(X,t)
∂S
∂Bφ
∂Bt
Figure 3.2: Large deformation of a solid. The solid has the initial configuration B ⊂ Ren
and deforms because of the external forces to S ⊂ Ren at time t ∈ T ⊂ Re. ϕ maps the
points on X to x and F is the material gradient of ϕ.
In the following sections, the phase variables, large deformations continuum mechan-
ics and diffusive cracks are introduced. In the fifth section, we discuss the constitutive
equations used in this model, hyperelasticity and anisotropicity. The sixth section is about
the active stress causing the cell migration. Then we focus on deriving the main Euler-
Lagrange PDEs. This is followed by a brief description of cell proliferation and the phase
change equations in section ten. The last part will present the matrix form of equations.
3.3 Field variables
Consider a deformable body at the time t = 0, the body is said to be in the reference
configuration at this time. The reference configuration is defined in an n-dimensional
setting by B ⊂ Ren and the material points are designated with X ∈ B as depicted
in Figure 3.2. The surface of B is defined as ∂B ⊂ Ren−1. In the same matter, the
deformed body at any time except the initial time (i.e. t 6= 0 | t ∈ T ⊂ Re) is defined by
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S ⊂ Ren. This configuration is called the spatial configuration and its surface is depicted
as ∂S ⊂ Ren−1. The transformation function mapping the material points to the spatial
point is called the deformation map ϕ(X, t). The deformation map is defined as
ϕt(X) :
 B × T → S,(X, t) 7→ x = ϕ(X, t). (3.1)
The other main field variable is the phase-field parameter d(X). The parameter is de-
fined on the entire reference configuration, B, and evolves as time proceeds. The phase-field
parameter of one represents an intact state, i.e. the extracellular matrix being untouched,
and zero represents cracked, i.e. endothelial cells moving into the ECM. As apparent in
Figure 2.4 there are several ways to make the transition between the two phases continu-
ous. The red plot is a second-order phase-field function, and the blue one is a fourth-order
function as apparent in Figure 2.4. Intuitively, it can be concluded that any values between
zero and one would mean that the material point is in the process of phase transition. The
phase-field parameter is defined as
dt(X) :
 B × T → [0, 1],(X, t) 7→ d = d(X, t). (3.2)
3.4 Large deformations main formulas
Biological tissues experience large deformations when subjected to external forces. The
continuum framework used in this research incorporates large deformations and nonlinear
geometry. Let’s start the discussion by defining the two different types of the gradient.
The material gradient is the gradient with respect to the reference configuration, and the
spatial gradient is the gradient with respect to the spatial coordinates. Equations 3.3 and
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3.4 show the two kinds of gradient respectively.
∇X = ∇ = ,X = d
dX
(3.3)
∇x = ,x = d
dx
(3.4)
in these equations,  (square) can be replaced by any investigated variable.
The first tensor to be defined in this framework is the deformation gradient tensor
which is the material gradient of the deformation map which can be depicted in matrix
form as
F = ∇ϕ = ϕ,X = dϕ
dX
=
dx
dX
(3.5)
and using the index notation it can be depicted as
Fij =
∂xi
∂Xj
= δij +
∂ui
∂Xj
. (3.6)
This tensor relates fibers’ length in the initial configuration to their length in the spatial
configuration; dx = FdX. The Jacobian of the deformation tensor relates the initial, dV ,
and the spatial, dv, infinitesimal volumes
J = det(F ) dv = JdV. (3.7)
The deformation gradient is unsymmetrical so the right, C, and the left, b, Cauchy-
Green tensor, or the Green and Cauchy deformation tensors respectively, are defined as
C = F TF , Cij = FkiFkj (3.8)
b = FF T , bij = FikFjk. (3.9)
The first tensor utilizes the Lagrangian configuration and the second one uses the Eulerian
configuration. There are n tensor invariants for a second-order tensor in an n-dimensional
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space. The three invariants for the matrix b are as follows:
I1 = tr(b) = bkk, I2 = 1/2[I
2
1 − tr(b2)] = 1/2[I21 − bikbki)], I3 = det(b) = J2. (3.10)
When the material is incompressible, as it the case with biological tissues, three other
invariants are used instead of the ones in 3.10. The new invariants are
I¯1 =
I1
J (2/3)
, I¯2 =
I2
J (4/3)
, J =
√
det(b). (3.11)
Note that J ≈ 1 in incompressible materials because dv ≈ dV .
The soft material used in the modelling is anisotropic. It means it has different char-
acteristics in different directions. There are two preferred directions in which the material
behaves stiffer. The two are shown with the vectors M and M ′. In the deformed material
they have the preferred directions m and m′ as shown in the Figure 3.4. More information
about the anisotropic behaviour is given in Section 3.6. The deformed preferred directions
are calculated as
m = FM , m′ = FM ′, or mij = FikMkj, m′ij = FikM
′
kj. (3.12)
The preferred directions can be shown in tensor form as
Am = m⊗m, Am′ = m′ ⊗m′ or Amij = mimj Am
′
ij = m
′
im
′
j. (3.13)
As mentioned in [62, 63, 66], five other pseudo-invariants can be used for the isotropic
media with two preferred directions which only two of them would be considered here.
The two are
I4 = m ·m, I6 = m′ ·m′, or I4 = mimi, I6 = m′im′i, (3.14)
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Figure 3.3: The phase-field representation of a line of endothelial cells at x = 0 and
extracellular matrix at ±∞ for a length-scale parameter equal to one. The green plot uses
Kronecker delta function for describing the different phases 3.15, the red and blue plots
use 3.16 and 3.17 respectively. The left side of the plots are the same as Figure 2.4.
3.5 Diffusive crack
As mentioned before, the main difference between the modelling approach used here and the
ones used in the previous biomechanical models is the implementation of fracture-based
phase-field modelling for the phase transformation1. Ginzburg-Landau type equations
would be used to describe the phase-field over the domain.
First, let’s assume an infinite one-dimensional medium L = [−∞,+∞] fully made of
the extracellular matrix d = 0. Endothelial cells are only present at x = 0. The classical
1Only [51] implemented the phase-field modelling without integrating the fracture mechanics.
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method to define the two phases is by use of the Kronecker delta function
d(x) = δij,j=0 = δ(x) =
1 x = 00 x 6= 0. (3.15)
The equation above looks like the Dirac delta function (green plot in Figure 3.3). The
problem is that this formula contains discontinuities which may cause numerical problems
in solving the differential equations2. To overcome the discontinuities, diffusive transition
would be assumed so the phase transition would be gradual throughout the domain. The
red plot in figure 3.3 is a second-order phase-field function which is continuous throughout
the domain and differentiable in all points except x = 0 as represented in equation 3.16.
d(x) = e−|x|/l. (3.16)
To have a phase-field equation which is differentiable throughout the domain the blue
plot can be used which is a fourth-order phase-field equation (3.17). It reduces the numer-
ical problems and is the best approach for isogeometric analysis [70, 71].
d(x) = e−2|x|/l(1 +
2|x|
l
). (3.17)
In the two equations 3.16 and 3.17, l is the length-scale of the transition topology. It shows
how wide the phase transition is. If l→ 0, it results in the green plot in Figure 3.3.
These two equations can be transformed into ordinary differential equations (ODEs)
with Dirichlet-type boundary conditions given below respectively.
d(x)− l2d′′(x) = 0, d(0) = 1, d(±∞) = 0. (3.18)
2 Phase-field analysis turns the discontinuity into continuity and the solves the problem. Alternatively,
extended finite element [67, 68] or phantom nodes [69] like approaches should be implemented to facilitate
solving the problem.
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d(x)− l
2
2
d′′(x) +
l4
16
(d(4)(x)) = 0, d(0) = 1, d′(0) = 0, d(±∞) = 0. (3.19)
As seen above, 3.18 is a second-order ordinary differential equation and 3.19 is a fourth-
order ODE which explains the naming for equations 3.16 and 3.17 respectively.
The formulas above can be transformed to Euler-Lagrange equations of the variational
principle for the second-order equation,
d = Arg
{
inf
d∈Wd
I(d)
}
, Wd = {d | d(0) = 1, d(±∞) = 0}
I(d) =
1
2
∫
B
(d2 + l2(d′)2)dx, (3.20)
and for the fourth-order equation,
d = Arg
{
inf
d∈Wd
I(d)
}
, Wd = {d | d(0) = 1, d′(0) = 0, d(±∞) = 0}
I(d) =
1
2
∫
B
(d2 +
l2
2
(d′)2 +
l4
16
(d′′)2)dx. (3.21)
The formulas 3.20 and 3.21 can be written in three-dimensional space in equations 3.22 to
3.25 respectively.
d(X, t) = Arg
{
inf
d∈WΓ(t)
Γl(d)
}
,
WΓ(t) = {d | d(X, t) = 1 @ X ∈ Γ(t)}, (3.22)
Γl(d) =
∫
B
γ(d,∇d)dV,
γ(d,∇d) = 1
2l
(d2 + l2 | ∇d |2). (3.23)
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d(X, t) = Arg
{
inf
d∈WΓ(t)
Γl(d)
}
,
WΓ(t) = {d | d(X, t) = 1,∇d(X, t) = 0 @ X ∈ Γ(t)}, (3.24)
Γl(d) =
∫
B
γ(d,∇d,∆d)dV,
γ(d,∇d,∆d) = 1
2l
(d2 +
l2
2
| ∇d |2 + l
4
16
| ∆d |2). (3.25)
In the formulas above, ∆ is the Laplacian and is defined as ∆ = ∇2 = ∇ · ∇.
Also, γ is called the volume specific transition surface. By minimizing the two variational
forms above in three-dimensional space, the Euler-Lagrange partial differential equation
d− l2∆d = 0 in B while ∇d ·N = 0 on ∂B (3.26)
would be obtained for 3.22 and
d− l
2
2
∆d+
l4
16
∆2d = 0 in B
while ∆d = 0 and [
l2
8
∇(∆d)−∇d] ·N = 0 on ∂B (3.27)
would be obtained for 3.24. In the formulas above, N is the normal vector to ∂B. In this
research project, the second-order formulas are used because of the lower computational
cost and the implementation of the classic finite element method shape functions instead
of the ones introduced in isogeometric analysis or the higher-order finite element method.
3.6 Constitutive model
The biological tissues are categorized into two types; soft tissues and hard tissue [72]. Hard
tissues are mostly bones and teeth, and soft tissues are the rest of the tissues in the body.
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Soft tissues consist of muscular, epithelial, nervous, and some of the connective tissues.
Arterial tissues’, a subgroup of muscular tissues, properties are used in this research for
modelling of the endothelial cells’ and the extracellular matrix’s mechanical response. In
this section, a brief explanation of the soft tissues characteristics will be presented first,
followed by the energy function and its derivatives.
3.6.1 Soft tissue’s mechanical characteristics
Hyperelasticity
The two-word definition for hyperelasticity is “nonlinear elastic.” So the strain-stress curve
is nonlinear, but the loading and unloading happen on the same curve. There is no need
for hysteresis, and only an energy function and a value for stress is enough to find the
strain at any given time.
Anisotropicity
Anisotropicity is a material having different material properties in different directions. In
blood arteries, there are some preferred directions which the soft material, both the blood
vessels and the extracellular matrix, behaves stiffer in those directions. This behaviour is
because the biological tissues are constituted of different materials which the main ones
are elastin and collagen proteins. Elastin behaves the same in every direction, and “is
the most linear elastic of the biosolid materials known” [73]. On the other hand, collagen
fibres only act in certain directions and cause the anisotropicity. A good analogy is to
compare the vessel wall with a reinforced concrete member. Elastin acts isotropically like
concrete with the difference of acting both in compression and tension. On the other hand,
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a collagen fibre works better in one direction just like the steel rebars with one difference
that collagen fibres only work in tension. The other difference is that in the vessel wall,
there is an infinite number of rebars in the selected directions. Recent studies indicate that
the number of preferred directions are different in different tissues [74]. Figure 3.4 shows
a tissue with two preferred directions before and after the deformation.
Heterogeneity
Heterogeneity is the state of having diverse properties at different points of the material.
The ECM and blood vessels are mostly defined by the average values of their mechanical
properties, but yet they are highly heterogeneous [24].
Incompressibility & viscoelasticity
Soft tissues are considered nearly incompressible because of their high water content. They
are also considered viscoelastic because their behaviour is a function of time [75, 76].
Hyperelasticity, anisotropicity, and incompressibility are recognized in the constitutive
model discussed below.
3.6.2 Formulization
As mentioned before, the energy function alone is enough to describe the mechanical be-
haviour of hyperelastic materials. The energy function is constituted of two parts, an
isotropic term for the elastin proteins and an anisotropic term for the collagen fibres’ ef-
fect. The isotropic term is a function of deformation invariants discussed in 3.11. Simple
material models, like the Neo-Hookean model [77, 78], make use of only I¯1 and J . For the
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anisotropic term, only two pseudo-invariants are used, each of the invariants is for one of
the fibre directions. The energy function is
Ψ0 = Ψ0(F ,Am,Am′) = Ψ
iso
0 (J, I¯1) + Ψ
ani
0 (I4, I6) = Ψ
iso
0 (J, I¯1) + Ψ
ani
0 (I4, I6), (3.28)
Ψiso0 (J, I1) =
µ1
2
(I¯1 − 3) + K1
2
(J − 1)2, (3.29)
Ψani0 (I4, I6) =
k1
2k2
∑
i=4,6
{exp(k2(Ii − 1)2)− 1}. (3.30)
The anisotropic term is based on [62] and defines an exponential function for each fibre
direction which behaves stiffer as the strain values go higher. Here, µ1 is the shear modulus
and K1 is the penalty parameter and the higher it is, the more incompressible the material
is. The parameters k1 and k2 are material constants. Note that µ1, K1, and k1 have the
unit of stress while k2 is dimensionless. Also, only the values over 1 for I4 and I6 are
considered because the collagen fibres work only when the fibre is engaged in tension. If
the fibres go through compression and each of the pseudo-invariants go under 1, the related
term for anisotropic energy would be zero. So, if the values for both I4 and I6 are less than
1, the material would behave completely isotropic. The preferred directions are shown in
Figure 3.4 in both initial and spatial configurations.
Passive true stress σ¯ij and passive Kirchhoff stress τ¯ij are defined as
σ¯ij =
1
J
Fik
∂Ψ
∂Fjk
and τ¯ij = Jσ¯ij = Fik
∂Ψ
∂Fjk
. (3.31)
Inserting the equations 3.29 and 3.30 in 3.31 results in
τ¯ iso,0ij =
µ1
J2/3
(Bij − 1
3
Bkkδij) +K1J(J − 1)δij (3.32)
and
τ¯ ani,0 = 2ψ,4m⊗m+ 2ψ,6m′ ⊗m′, τ¯ani,0ij = 2ψ,4mimj + 2ψ,6m′im′j. (3.33)
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Figure 3.4: The top figure shows the anisotropic material in nondeformed configurations
with two preferred directions M and M ′. The bottom figure shows them in the spatial
configuration with the two directions m = FM and m′ = FM ′. Red shows the elastin
protein which governs the isotropic response of soft tissues.
In equation 3.33 ψ,i=4,6 is the derivative of the energy function with respect to the psuedo-
invariants
ψ,i=4,6 = ∂IiΨ0 = k1(Ii − 1) exp
(
k2(Ii − 1)2
)
. (3.34)
The tangent stiffness tensor or the Eulerian elasticity tensor is defined as
Cijkl =
∂τij
∂Fkm
Flm = Jσijδkl + J
∂σij
∂Fkm
Flm. (3.35)
So using the same approach the isotropic and the anisotropic terms are
Ciso,0ijkl =
µ1
J2/3
(δikBjl +Bilδjk− 2
3
(Bijδkl +Bklδij) +
2
3
Bqq
3
δijδkl) +K1(2J − 1)Jδijδkl (3.36)
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and
Cani,0 = 4ψ,44m⊗m⊗m⊗m+ 4ψ,66m′ ⊗m′ ⊗m′ ⊗m′,
Cani,0ijkl = 4ψ,44mimjmkml + 4ψ,66m
′
im
′
jm
′
km
′
l, (3.37)
with ψi=4,6,ii being the second derivative of the energy functions with respect to the pseudo-
invariants
ψi=4,6,ii = ∂Iiψ,i = k1(1 + 2k2(Ii − 1)2) exp
(
k2(Ii − 1)2
)
. (3.38)
3.7 Active stress
The stress value equations in the last section only account for the passive stress generated
by the material in response to some other sources of stress or deformation. The total stress
is the summation of the active and passive stress
τ = τact + τ¯ = τact + τpas. (3.39)
The active stress is a contraction stress caused by the tip cells trying to migrate towards
the TAF source [51]. Extensive experiments have been conducted to study the active stress
caused by the tip cells in migrations. Reinhart-King observed that the tip cell generates the
most traction stress close to its walls and the least in its center [7, 6]. Edgar [5] believed that
the traction’s magnitude is maximum at the point of the tip cell and decreases exponentially
with radius. Combining the results from the two researchers, an exponential function for
the active stress value is developed here by changing the formula proposed by Edgar so the
stress first increases around the tip cell’s center point until it reaches the tip cell’s walls,
then it disperses exponentially (Figure 3.5). It was also said that the value of active stress
would be maximum towards a tumour and decreases in other directions (Figure 3.6).
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Figure 3.5: The term e−b(‖r‖−r0)
2
in 3.41. It shows the intensity of the active stress with
respect to distance. As seen in this figure, the magnitude of active stress increases until
it reaches cell walls and then decreases exponentially. b = 2 × 106 r0 is assumed in this
figure.
When the tip cell is at point xs, the active stress at any arbitrary point x can be
calculated using the formulas (Figure 3.7),
r =‖ r ‖ rˆ = xs − x, (3.40)
τact = Jae
−b(‖r‖−r0)2
∣∣∣cosN(α
2
)
∣∣∣rˆ ⊗ rˆ, (3.41)
α = ψ − θ. (3.42)
The part rˆ⊗ rˆ in 3.41 defines the direction of the stress tensor radial towards the tip cell.
N , a, and b are parameters for adjusting the width, the magnitude, and the range of the
stress field, respectively. In Figure 3.7, ev is a unit vector towards the TAF source, and
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Figure 3.6: The term
∣∣cosN(α
2
)
∣∣ in the active stress formula. α = 0 is the direction of the
tip cell migration in the time step. As shown, increasing the value for N decreases the
width of the stress field and makes it more concentrated towards the migration direction.
ev2 is a unit vector showing the direction of the tip cell movement. This direction, e
v
2, is
calculated by rotating ev by θ. The value of θ is discussed in the next chapter.
The formula above is multiplied by a term to account for the effect of TAF level on the
magnitude of active stress. The term is presented in [35, 30] and accounts for the decrease of
chemotactic sensitivity with the increase of TAF concentration. It has a Michaelis-Menten
rate law form as
1
1 + βξ
, (3.43)
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Figure 3.7: The tip cells generate active stress on the media. The location of the tip cell
is represented by TC and the stress can be calculated at any point of x. The unit vector
ev is directed towards the maximum TAF gradient and ev2 shows the direction of the tip
cell movement.
in which, ξ is the dimensionless TAF concentration and β is a dimensionless constant. The
higher β is, the easier for the endothelial cells is to lose their chemotactic sensitivity. Other
biomechanical variables can also affect the active stress. To see how active stress formulas
are linked to the ECM density, please refer to [79].
The final value for active stress is shown below,
τact =
1
1 + βξ
Jae−b(‖r‖−r0)
2
∣∣∣cosN(α
2
)
∣∣∣rˆ ⊗ rˆ. (3.44)
3.8 Degradation function
The mechanical energy storage function for a multi-phase medium can be defined as [80]
Ψ(F ,Am,Am′ , d) = g(d)Ψ
ECM
0 (F ,Am,Am′) + (1− g(d))ΨEC0 (F ,Am,Am′). (3.45)
Here, g(d) is the degradation function; it correlates the amount of phase transition to the
change in mechanical energy storage. The equation above is an interpolation between the
two values of energy for the ECM and the ECs so the value of g(d) should be to be between
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Figure 3.8: The quadratic and the cubic degradation functions for correlating the phase
transition and mechanical energy storage.
0 and 1. All the conditions needed for g(d) are
g′(d) ≤ 0, g(0) = 1, g(1) = 0, g′(1) = 0. (3.46)
The most popular equations for the degradation function are the quadratic
g(d) = (1− d)2, (3.47)
and the cubic
g(d) = m[(1− d)3 − (1− d)2] + 3(1− d)2 − 2(1− d)3 (3.48)
equations (Figure 3.8). The cubic function is newer and it has been proposed in 2016 [81]
by Borden. He proved that the cubic equation functions better in linear elastic problems.
The quadratic equation is used for this research for its computational efficiency.
In the same way as the energy function, the active stress and the stiffness tensor are
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interpolated as
τ pasij = Fik
∂Ψ
∂Fjk
=Fik
∂(g(d)ΨECM0 + (1− g(d))ΨEC0 )
∂Fjk
= g(d)τECMij0 + (1− g(d))τECij0 ,
(3.49)
Cijkl =
∂τij
∂Fkm
Flm =
∂(g(d)τECMij0 + (1− g(d))τECij0 )
∂Fkm
Flm
= g(d)CECMijkl0 + (1− g(d))CECijkl0 .
(3.50)
3.9 Derivation of the main two PDEs
In this section, using the minimization principle for the global power balance, the two main
PDEs are derived.
First, an isotropic medium with no phase transition is considered. The energy storage
function is
E(ϕ) =
∫
B
Ψ(F ,Am,Am′)dV, (3.51)
and the external work function is defined as
P (ϕ) =
∫
B
ρ0γ¯ ·ϕdV +
∫
∂B
T¯ ·ϕdA. (3.52)
In the formula above, ρ0 is the density, γ¯ is the prescribed body force and T¯ is the
prescribed traction. All three are defined in the reference configuration. Also, note that Ψ
is the free-energy function per unit volume in the reference configuration. The balance of
the two formulas above are minimized below
ϕ = Arg
{
inf
ϕ∈Wϕ
E(ϕ)− P (ϕ)
}
. (3.53)
The Dirichlet-type boundary conditions below are assigned to the minimization equation
Wϕ = {ϕ | ϕ ∈ H1(B),ϕ = ϕ¯ in ϕ¯ ∈ ∂Bϕ}. (3.54)
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Solving equation 3.53 using the boundary conditions 3.54 the PDE below with the Neumann-
type boundary conditions stated is derived
∇X · P + ρ0γ¯ = 0→ ∇ · P + ρ0γ¯ = 0 BC: P ·N = T¯ on ∂Bt. (3.55)
Now, the same approach as above, for a multi-phase medium would be used. The
formulas derived here are the main formulas used in the biomechanical module. This time
the energy storage function is defined using the free-energy function in 3.45 as below
E(ϕ, d) =
∫
B
Ψ(F ,Am,Am′ , d)dV. (3.56)
The external work function is the same as 3.52. Differentiating the energy storage function
with respect to time results in rate of energy storage function
E(ϕ˙, d˙,ϕ, d) =
∫
B
(P : F˙ − fd˙)dV. (3.57)
In the formula above, P is the first Piola-Kirchhoff stress tensor
P = ∂FΨ(F ,Am,Am′ , d) (3.58)
and f is an energetic force conjugate to the crack phase-field
f = −∂dΨ(F ,Am,Am′ , d). (3.59)
In the same way, by differentiating the external work function with respect to time, its
rate is derived
P(ϕ˙) =
∫
B
ρ0γ¯ · ϕ˙dV +
∫
∂B
T¯ · ϕ˙dA. (3.60)
Note that in the problem in this research, the terms in external work function are all zero
because all the external effects are shown in active stress in the stress term in the energy
storage function.
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Another difference that the multi-phase energy formulas have with the formulas derived
at the beginning of this section is the introduction of a new energy term. This term is
called the transition energy function and is the amount of energy dissipated for the rupture
of the ECM and the take over of the ruptured area with ECs
Dc(d) =
∫
B
gt
2γ(d,∇d)dV. (3.61)
In the equation above, gt is the critical energy needed to occupy the ECM space with
the ECs and  is the normalized ECM density discussed in the next chapter. Note that
this parameter is always between zero and one so it reduces the energy needed for rupture.
Differentiating this energy term with respect to time gets the transition dissipation function
Dc(d˙) =
∫
B
gt
2(δdγ(d,∇d))d˙dV, (3.62)
δdγ(d,∇d) = 1
l
(d− l2∆d). (3.63)
Power balance equation is simply written by setting the summation of 3.57, 3.60, and
3.62 to zero
Π (ϕ˙, d˙) = E(ϕ˙, d˙) +D(d˙)− P(ϕ˙) = 0. (3.64)
It can be written in the form of equation 3.53
{ϕ˙, d˙} = Arg
{
inf
ϕ∈Wϕ
inf
d∈Wd
Π (ϕ˙, d˙)
}
(3.65)
with Wϕ and Wd defined as
Wϕ = {ϕ˙ | ϕ˙ = 0 on ∂Bϕ}, Wd = {d˙ | d˙ = 0 on ∂Bd}. (3.66)
Solving the minimization problem above, the two PDEs below are derived
∇ · P + ρ0γ¯ = 0 (f − gt2δdγ)d˙ = 0. (3.67)
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The first PDE above can also be written as
J∇x · (J−1τ ) + ρ0γ¯ = 0 (3.68)
with τ denoting the Kirchhoff stress as defined in 3.31. As seen here, the first PDE is the
same as the PDE seen for simple one-phase problems in 3.55. In the next section, we talk
a little about the second PDE.
3.10 Phase change
The second PDE in 3.67 is discussed here, irreversibility of phase transition and mitosis
will be added to the formulation.
First, using 3.63 and the second equation in 3.67, results in
f − gt
2
l
(d− l2∆d) = 0 (3.69)
and considering 3.59 leads to
f = fECM − fEC = 2(1− d)(ΨECM0 −ΨEC0 )
→
f
ECM − (gECMt /l)2(d− l2∇d) = 0
fEC − (gECt /l)2(d− l2∇d) = 0.
(3.70)
In this formula, gECMt is the critical energy needed for breaking the bonds in the ECM and
gECt is the energy needed for the formation of the ECs. Only the formula for the ECM is
taken to account here to calculate the value for d. Renaming gECMt to gc and decomposing
fECM to isotropic and anisotropic responses and solving 3.69 for each response results in
Ψiso0 = Ψ
ECM
iso,0
, Ψani0 = Ψ
ECM
ani,0
, (3.71)
2(1− d) Ψ
iso
0
gisoc 
2/l
= d− l2∆d, 2(1− d) Ψ
ani
0
ganic 
2/l
= d− l2∆d. (3.72)
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Now, dimensionless mechanical transition driving functions for both responses can be
defined as
H¯iso = Ψ
iso
0
gisoc 
2/l
, H¯ani = Ψ
ani
0
ganic 
2/l
. (3.73)
The total mechanical transition driving function can be defined as the summation of the
two so 3.69 would be transformed into
H¯ = H¯iso + H¯ani → d− l2∆d = (1− d)H¯. (3.74)
Now the irreversibility condition would be added to the formula above with defining the
history function H¯ as below
H = max
s∈[0,t]
[〈H¯(s)− 1〉]. (3.75)
Here, 〈〉 is the Macaulay brackets and is defined as 〈〉 = (+ ||)/2. This function
simply makes the value of H either be constant or increase in each time step (Figure 3.9).
Also note that the minus one is there so that the phase transition would not start with
any values of deformation. It would start when the Ψ0 is more than the critical value gc/l.
Note that the formula above provides an energy-based failure criterion for mode I fracture.
Mode I of fracture is the propagation of the crack because of tensile stress normal to plane
of the crack. Stress-based failure criteria are provided in [61].
As mentioned in [48] a new term can be added to 3.69 to account for cell mitosis
f − gc
l
(d− l2∆d) + νd(1− d)〈ω − ωt〉 = 0. (3.76)
In the formula above, ν is the proliferation constant for the endothelial cells and ωt is
the critical value of TAF concentration for the start of the proliferation. Also, ω is the
normalized TAF concentration which is always between 0 and 1. Repeating everything
done in this section, the formula below would be derived for irreversible phase transition
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Figure 3.9: The relationship between the history function H and the total mechanical
transition driving function H¯.
with mitosis
d− l2∆d︸ ︷︷ ︸
Geometric resistance
= (1− d)H︸ ︷︷ ︸
Driving force
+ νcd(1− d)G¯︸ ︷︷ ︸
Proliferation
, G¯ = 〈ω − ωt〉, νc = ν
gc/l
. (3.77)
Note that the formula above and 3.74 are the main difference between the modelling
framework in this research and the framework in other works on angiogenesis [30, 26, 48,
82]. In other research projects, there is no correlation between the biomechanical aspects
of angiogenesis and ECs migration towards a tumour. Instead, they offer a term for
chemotaxis which in this work is taken care of with the active stress term 3.39. They also
model haptotaxis, related to ECM degradation, with a term in their phase-transition like
PDE which is modelled here with  in 3.73.
Refer to [82] to see sever al other terms like a term for natural degradation and a term
for necrosis of the ECs.
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3.11 Numerical implementation
In this section, the matrix form of formulas used in the computer code would be explained.
To solve the two PDEs in 3.67, the staggered (as named in [59]) or the one-pass operator-
splitting (as named in [3]) algorithm would be used. In this method, in every iteration, the
two PDEs would be solved separately with the assumption of the other field variable staying
constant. Here, first the displacement PDE would be solved, then the history function
would be calculated over the domain followed by second PDE. This loop is repeated until
convergence is met. The three steps are shown below.
→ (1) J∇x · (J−1τ ) + ρ0γ¯ = 0 & d˙ = 0,
→ (2) H = max
s∈[0,t]
[〈H¯(s)− 1〉],
→ (3) d− l2∆d = (1− d)H & ϕ˙ = 0.
(3.78)
Discretizing the space of field variables and the reference domain B into subdomains
∂Bˆ will result in the equation
R =
Rϕ
Rd
 = 0. (3.79)
In this equation, R is the residual vector and Rϕ and Rd are the residual vectors for
deformation and phase transition respectively. The formula above and the PDEs in 3.78
with the assumption of γ¯ and T¯ being equal to zero can be written in indicial form as
follows
Rˆaϕ,i =
∫
Bˆ
(
∂N a
∂xj
τˆij
)
dV = 0,
Rˆad =
∫
Bˆ
(
N a
(
dˆ− (1− dˆ)Hˆ
)
+
∂N a
∂Xj
lˆ2
∂dˆ
∂Xj
)
dV = 0,
(3.80)
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. Note that the sign ˆ shows that the quantities in the formulas above are associated with
each element, for example, Hˆ is the value of the history function in each element or Rˆaϕ,i is
the value of the residual vector of the balance of linear momentum PDE in each element
which needs to be assembled in the global residual vector. Also, the formulas are written
for each node and each degree of freedom shown with the a superscript and i, j subscripts
respectively. Here, τˆij is the Kirchhoff stress in each element and is calculated using 3.39.
N a is a scalar and contains the shape function for each node a.
The above nonlinear equations need to be linearized to be solved. The linearization
process is done by using the first two terms of the Taylor series
R+
∂R
∂U
∆U = 0. (3.81)
In this equation U contains the phase variables as
U =
ϕh
dh
 . (3.82)
There is a stiffness term also apparent in 3.81 which can be defined as follows
K =
∂R
∂U
=
∂Rϕ/∂ϕ 0
0 ∂Rd/∂d
 =
Kϕϕ 0
0 Kdd
 . (3.83)
The two stiffness matrices above for the nodes a, b and the degrees of freedom i, k in each
element can be calculated with
Kˆabϕϕ,ik =
∫
Bˆ
(
∂N a
∂xj
Cˆijkl
∂N b
∂xl
− ∂N
a
∂xk
τˆij
∂N b
∂xj
)
dV,
Kˆabdd,ik =
∫
Bˆ
(
N a
(
1 + Hˆ
)
N b + ∂N
a
∂Xj
lˆ2
∂N a
∂Xj
)
dV,
(3.84)
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in indicial form. As a result, the equation 3.78 can be written in matrix form as
→ (1) ∆ϕh = −K−1ϕϕRϕ,
→ (2) H = max
s∈[0,t]
[〈H¯(s)− 1〉],
→ (3) ∆dh = −K−1dd Rd.
(3.85)
3.12 Conclusion
This chapter discussed the different components and the flow of the code. It explained
the biomechanical module and the basic knowledge needed to comprehend it. All the
equations presented here are borrowed from mentioned references except equations 3.44
and 3.61 which are modified to capture the physics of this problem better. At the end of
running this part of the code, the stress and displacement fields and the propagation of
the endothelial cells are calculated and will be passed on to the vascular network module.
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Chapter 4
Biochemical & Vascular Network
Modules
This chapter talks mainly about the two remaining modules in the solver. First, the
biochemical module and then the vascular network module.
4.1 The biochemical module
This module is run once at the beginning of each time step. It uses the values of biochemical
concentrations and the deformations from the previous time step to produce the new values
for the concentrations and their rate of change. Because the PDEs in this module are both
time and space dependent, both spatial and time discretization are required.
As seen in Figure 3.1A, this module first calculates the concentration of oxygen and
MDE throughout the domain, then the values for TAF and the ECM level. The formulas
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are based on mass conservation and Fick’s laws, and the time integration is done using
Crank-Nicolson method.
In this section, an approach like the one taken in the third chapter would be made. It
will start with defining the field variables. Then the derivation of the formulas and their
matrix form used in the solver will be presented.
4.1.1 Field variables
Four field variables are defined in this module representing the normalized values for con-
centrations that range between 1 and 0. Normalization is done by setting a maximum
value for each of the four and then dividing the values for each concentration by that con-
centration. These phase variables are defined on the initial configuration, B, and evolve
with time. The four variables are normalized concentrations for oxygen, TAF, MDE, and
the ECM’s normalized density, denoted by ξt(X), ωt(X), µt(X), t(X), respectively. All
the four can be defined as
t(X) :
 B × T → [0, 1],(X, t) 7→  = (X, t). (4.1)
4.1.2 Fluxes, diffusion, and advection
Mass conservation equation and Fick’s first law result in the advection-diffusion-reaction
equation
dc
dt
= −∇ · Jc + Pc −Qc, (4.2)
where c is the dimensionless normalized concentration. Jc is the diffusive flux of c. Pc and
Qc are the production and consumption rates, respectively. Using Fick’s second law, the
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diffusive flux can be defined as Jc = −Dc∇c so the mass transfer formula becomes
dc
dt
= Dc∆c+ Pc −Qc. (4.3)
The material derivative of normalized concentration (dc)/(dt) can be defined as
dc
dt
=
∂c
∂t
+
∂c
∂x
· ∂x
∂t
, (4.4)
the second term here can be interpreted as the advection term when the flow is incom-
pressible [83].
4.1.3 Reactions
The consumption rate in 4.3 is assumed to be only dependent on the species decay. The
simplest decay model for a species is a linear decay with the reaction rate δc and only
dependent on the substrates concentrations [84]. The decay process for Oxygen, TAF, and
MDE can be depicted as
C
δc−−−→
Qc = δcc.
(4.5)
The decay of the ECM needs two substrates. It needs both ECM and MDE to decay
so the formulas will be as
ECM + MDE
δ−−−→
QECM = δµ,
(4.6)
where δ is the decay rate. The normalized concentrations of ECM and MDE are  and
µ respectively. Note that the formula only applies to the domain which tumour does not
exist. The MDE does not degrade the tumour cells. To incorporate this into the formula,
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a parameter ρ¯tum can be defined which is equal to 0 where there is tumour and is equal to
1 anywhere else. Now 4.6 can be multiplied by ρ¯tum.
The easiest assumption for calculating the production rate is having an unlimited
amount of substrates. This would result in a constant rate of production λc defined as
(if cond)
λc−−−→ C,
P c = ρcondλc,
(4.7)
which if a certain condition satisfies for each substrate in an element, then a constant rate
is assumed or else the rate is zero. The first ρcond is ρtum which shows where the tumour
is so ρtum is equal to 1 on the tumour and is equal to 0 everywhere else. The second ρtum
is ρv, a parameter to show where vessels exist so it is equal to 1 on the capillaries and
0 on the ECM. Finally, ρt is equal to 1 in elements where tip cells exist and equal to 0
everywhere else. The three production rates are
Pξ = PO2 = ρvλξ
Pω = PTAF = ρtumλωexp(−2ξ/ξ¯)
Pµ = PMDE = ρtumλµ−c + ρtλµ−v.
(4.8)
4.1.4 Final PDEs
Setting the values for consumption and production rates for the four substrates in equation
4.3, results in the four equations
dξ
dt
=
∂
∂X
· [Dξ ∂ξ
∂X
]︸ ︷︷ ︸
Diffusion
+ ρvλξ︸︷︷︸
Production
− δξξ︸︷︷︸
Decay
, (4.9)
dω
dt
=
∂
∂X
[Dω
∂ω
∂X
] + ρtumλωexp(−2ξ/ξ¯)− δωω, (4.10)
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dµ
dt
=
∂
∂X
[Dµ
∂µ
∂X
] + ρtumλµ−c + ρtλµ−v − δµµ, (4.11)
d
dt
= −δρ¯tumµ, (4.12)
where ξ and ω are the values for the normalized concentration of oxygen and TAF respec-
tively.
Equations 4.9 and 4.11 give the values for oxygen and ECM concentrations independent
from the values for the other two substrates. So, to solve the system of PDEs, at first
equations 4.9 and 4.11 are solved and then, the other two equations are solved.
4.1.5 Numerical implementation
The two main differences between the formulas derived here and the ones obtained in the
previous chapter 3.67 are that the equations derived in this chapter are linear and time-
dependent while the formulas in the other chapter where nonlinear and time independent.
This time dependency requires the discretization of the PDEs both in time and space.
Crank-Nicolson method [85] does the discretization in time. This method needs two steps
to solve each of the PDEs. The two steps are
→ (1) dn+1c =
(
An+1
)−1
Rn+1,
→ (2) d˙n+1c =
2
∆t
(
dn+1c − dnc
)
− d˙nc .
(4.13)
In the formulas above, the superscript in n+1 shows the time step and ˙ shows the deriva-
tive with respect to time. The vector dc contains the value of normalized concentration
for each ξ, ω, µ, and  so in a four-node element is a 4 × 1 vector. The time step size is
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defined with ∆t. The matrix An+1 and the vector Rn+1 are defined as
An+1 = C +
∆t
2
Kn+1t , (4.14)
Rn+1 =
∆t
2
fn+1 +
∆t
2
(
Cd˙nc
)
+Cdnc . (4.15)
In the two formulas above, the definition ofKn+1t and f
mn+1 are dependent on the substrate
as shown below.
if material = ECM → Kn+1t = Km
n+1
t = K
n+1
adv +U
mn+1 ,
→ fmn+1 = 0.
other → Kn+1t = Kc
n+1
t = K
n+1
adv +U +K,
→ f cn+1 = P n+1c .
(4.16)
Matrix C in equation 4.15 and the five new matrices above are defined as
Kˆabadv =
∫
Bˆ
(
N aviDil∂N
b
∂Xl
)
dV, Kˆab =
∫
Bˆ
(
∂N a
∂Xi
Dc
∂N b
∂Xi
)
dV,
Cˆab =
∫
Bˆ
(
N aN b
)
dV, Pˆ a =
∫
Bˆ
(
N aPˆ
)
dV,
Uˆm
ab
=
∫
Bˆ
(
N aµˆN b
)
dV, Uˆab = δcCˆ
ab.
(4.17)
The notation here is the same as the one used in chapter 3.11. Note that Pˆ is calculated
from 4.8. Matrix D is defined in the same fashion as the deformation gradient in 3.5 and
v is the velocity vector,
D =
dX
dϕ
=
dX
dx
, Dil =
∂Xi
∂xl
,
v =
dv
dt
, vi =
∂xi
∂t
.
(4.18)
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Figure 4.1: A branch in angiogenesis. Except tumour location, all the data presented here
are all the biochemical and biomechanical data needed for vascular network module.
4.2 The vascular network module
The last module in the solver is the vascular network module. In contrast to the other
modules, this module is not about solving any PDEs and the most computational intensive
calculation done in it is solving a one-dimensional nonlinear equation using the Newton-
Raphson method. This module is run at the end of each time step and calculates the force
at each tip cell, checks if there is a need for the movement of the tip cell, and finds its new
location. All these are discussed in the first subsection. The second subsection presents
branching formulations.
4.2.1 Update tip cells
This sub-module first calculates the magnitude of force at each of the tip cells linearly,
based on whether the tip cell is on the rising phase or not (all the tip cells k−4, k−3, ..., k
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tn
Figure 4.2: Loading on different locations of the tip cell throughout the time. The load
factor is a dimensionless parameter which will be multiplied to equation 3.44 in each time
step to calculate the active stress. This figure shows that in the vicinity of t = tn the load
factor for the tip cell k−1 is decreasing and increasing for tip cell k. Figure 4.1 corresponds
to t ∈ [tk, tk+1].
in Figure 4.1). When a new tip cell is formed, it is defined in the rising phase, and the
previous tip cell on the same branch will be marked in decline phase. In problems here
only the last two of the tip cells have a value other than zero. The load factor change with
time for Figure 4.1 is depicted in Figure 4.2. The last two tip cells can be interpreted as a
stretched tip cell as seen in [7, 6].
Then the last tip cells in each of the branches (tip cell k) is checked to see if the phase
transition parameter d(r) in each of them exceeds dmax, if it does, the search for the new
tip cell in that branch will be started (tip cell k + 1).
The new tip cell is found in the direction of the ev2 (Figure 4.3A) as defined in Figure
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Figure 4.3: A: The direction of the next tip cell. B: The evolution of the transition
parameter in the ev2 direction from the point r
k and the distance (∆r) of the next point
rk+1 from the point rk.
3.7. The formulas for calculating ev2 are
ev =
∇ω(rk)
‖ ∇ω(rk) ‖ , (4.19)
ev2 = A(θ)e
v, (4.20)
where rk is the location of the tip cell k andA(θ) is the transformation function rotating ev
by θ. The angle θ is calculated using the normal distribution to account for the stochastic
movement of the tip cell.
When the direction of the next tip cell is found, its location is calculated as (Figure
4.3B)
∆dv = ∇d(r) · ev2,
∆r =
d(r)− d0
∆dv
,
rk+1 = rk + ev2∆r.
(4.21)
In the formulas above d0 is the initial transition value at the tip cell k + 1.
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4.2.2 Branching
Most of the branching models in the literature use probability functions in each time step
on unbranched areas of the newly formed vessel to see if branching happens or not. In
these models, a random number for each of the previous tip cell locations using the uniform
distribution would be generated. These numbers are between 0 and 1. The probability of
branching is B, and if the random number is smaller than B, then branching occurs in the
selected previous tip cell.
The same is implemented in this solver for branching. If the steps above indicates that
branching is required, the solver searches for the next tip cell that originates from the node
that caused the branching. The equations 4.20 and 4.21 would be used to find the new tip
cell with a small difference. Now, θ2 would be used instead of θ which is defined as
θ2 = θ + θ0 (4.22)
with θ0 being a constant.
Here, B is assumed constant but as referred in [5, 30, 26] it can be a function of TAF
concentration, the age of the vessels, the distance of the point from a tumour, or the
biofluidic parameters like wall shear stress in the capillaries.
4.3 Conclusion
This chapter first discussed the biochemical module and presented a set of four partial
differential equations to model the concentration of each substrate in the domain. This
module uses the displacement field generated by the biomechanical module as an input.
The chapter then discusses the vascular network module which is the most innovative part
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of this chapter. This module uses the phase transition data to find the next tip cell location
in each time step and check for branching. The components discussed in this chapter and
the one before it complete the engine needed for this new approach to analyze angiogenesis.
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Chapter 5
Results and Discussion
The previous chapters discussed the theoretical aspects and the numerical implementations.
This chapter covers the specifics about the model and the results. The specifics include the
values for parameters, the geometry, and the initial and boundary conditions. The results
are generated for a certain problem, and are discussed in the last section of the chapter.
The final thoughts are presented in the next chapter.
5.1 Parameters
Different parameters are investigated through this model. Just as the modules, they can be
classified as biochemical, biomechanical, and vascular parameters and they are represented
by the three following tables. Table 5.1 contains the biochemical parameters as reported
in [1]. Note that the parameterless entries in the table are the value used to make the
concentration values, ω, ξ, µ, , dimensionless. Also, note that the oxygen uptake is different
in the tumour and the host.
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Table 5.1: Biochemical parameters [1]
Substrate Description Parameter Value Unit
TAF
production rate λω 9.996 d
−1
decay rate δω 8.64× 10−2 d−1
diffusion coefficient Dω 9.99× 10−1 mm2 d−1
max concentration − 1× 10−8 g cm−3
Oxygen
production rate λξ 0.288 d
−1
uptake by the host δξ 1.38× 10−3 d−1
uptake by the tumour δξ 1.725× 10−2 d−1
diffusion coefficient Dξ 3.455× 10−3 mm2 d−1
TAF related parameter ξ 0.6 −
MDE
tumour’s production rate λµ−c 4.32× 10−2 d−1
TC’s production rate λµ−v 8.64× 10−3 d−1
decay rate δµ 1.0368× 102 d−1
diffusion coefficient Dµ 7.344× 10−1 mm2 d−1
max concentration − 1× 10−13 Mol cm−3
ECM
degradation rate δ 6.912 d
−1
reference density − 0.1 g cm−3
Table 5.2 contains parameters and their values for the biomechanical module. The
values for the mechanical properties of both the ECM and the ECs are derived from
[51, 3, 86]. As seen in the table, the anisotropic parameters related to the endothelial cells
are zero because it is assumed that it takes some time for the network of collagen fibres to
56
Table 5.2: Biomechanical parameters [2, 3, 4, 5, 6, 7]
Category Description Parameter Value Unit
EC
shear modulus µEC1 5.0× 10−3 MPa
penalty term KEC1 5.0 MPa
stress-like material parameter kEC1 0 MPa
dimensionless parameter kEC2 0 −
ECM
shear modulus µECM1 1.0× 10−2 MPa
penalty term KECM1 10 MPa
stress-like material parameter kECM1 2.0× 10−2 MPa
dimensionless parameter kECM2 1.0 −
Phase
transition
length-scale parameter l 2.0× 10−2 mm
critical transition energy gisoc 5.0× 10−4 MPa mm
critical transition energy ganic 1.5× 10−3 MPa mm
Active
stress
magnitude a 0.200 MPa
range b 1.4× 104 mm−2
width N 2 −
EC’s radius r0 1.4× 10−2 mm
Michaelis-Menten coefficient β 0.6 −
form in the newly-constructed capillaries. The phase transition parameters are taken from
[2, 3, 4]. Finally, stress-related equation was developed based on [5] and calibrated with
experimental data provided by [6, 7].
To our knowledge, no parameters required for the vascular network module are available
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in the literature. To find the value of parameters reported in 5.3 required for our model,
we ran our model several times (trial and error) using the examples reported in [26] until
the same results are reached.
Table 5.3: Vascular parameters
Sub-module Description Parameter Value Unit
Tip cell
migration
production rate dmax 0.20 −
decay rate d0 0.15 −
mean for θ in 4.20 − 0.0 −
standard deviation for θ in 4.20 − pi/18 −
Branching
branching probability B0 0.1 −
new sprout angle θ0 pi/2 −
5.2 Initial and boundary conditions
There are six partial differential equations in this analysis. Boundary and initial conditions
are defined for each of the PDEs. Two types of boundary conditions exist in this problem.
Neumann boundary conditions which specify the value of the normal derivative of the
functions are already included in the formulations (3.26) but will be included here for
convenience.
T¯ = 0 , ∇d ·N = 0 on ∂B,
qω = qξ = qµ = q = 0 on ∂B. (5.1)
The values for q show the flux of  on the boundaries.
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Dirichlet boundary condition is only defined for the first PDE, the deformations PDE.
This type of boundary condition defines the value of the function on the boundaries. Here,
the deformation is set to be zero in the normal direction to the boundary.
The initial values (t = 0) for the deformation PDE are the deformation being equal
to zero throughout the domain. So the system is at rest mechanically at the beginning.
The phase transition is set to zero over the domain, so the entire domain is filled with the
extracellular matrix at the beginning. The nodes with the parent vessel on them will have
H = 5.0. Equation 3.74 calculates the value for the phase-field parameter using the initial
value for H in the first time step so by the end of the initial time step the location of the
parent vessel is set.
The rate of change for all the biochemical concentrations is set to zero at the initial
time. The concentrations for MDE and TAF are also supposed to be zero throughout the
domain at time zero. The normalized oxygen concentration is equal to one throughout the
domain except inside the tumour where it is equal to zero to account for the hypoxia (as
an extreme case) inside the tumour initiating the tumour-induced angiogenesis. The initial
normalized ECM density is equal to one.
5.3 Geometry
All the problems solved in this project are defined in the two-dimensional space. Bilinear
quadrilateral elements are used in the analysis with the plane strain assumption. The
domain is a square with the dimension of 0.4 mm. The geometry is depicted in Figure 5.1.
The result of the Dirichlet boundary conditions explained in the previous section is simple
supports constraining the movement of the boundaries in their normal directions, so the
top and bottom boundaries constrain the movement in y-direction and the left and right
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Figure 5.1: The general geometry of the examples solved here. The parent vessel is gener-
ated in the first time step. Dimensions in the figure are in mm.
boundaries constrain the movement in x-direction. According to [2], the maximum value
for the element size is half of the value of l. So, the element size h = 0.01 is used here.
The tip cell is at (0.2, 0.08) initially for the first, second, and the last examples and it
later moves towards the tumour in the next time steps using the vascular network module.
5.4 Models and discussion
This section contains four models. They are different in the vascular network module and
initial conditions. The first model has no stochastic movement, θ in 4.20 is equal to zero.
Next models get more detailed with the guided random walk, more initial tip cells, and
branching, each added in the second, third, and fourth model, respectively. The differences
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between the four models are demonstrated in Table 5.4.
Table 5.4: Differences between the four models
Model Stochastic Movement Number of tip cells Branching
I 7 1 7
II 3 1 7
III 3 2 7
IV 3 1 3
5.4.1 Model I: No stochastic movement
In this model, the normal distribution which produces the values for θ in 4.20 is turned off.
Figure 5.2 shows the resulting phase transition at four different time steps. The parent
vessel and the tumour location is the same as the one depicted in 5.1. The maroon area
is the location of a tumour. The white dots show the path of the movement of the tip
cell. The first tip cell is on the parent vessel wall. The tip cell moves upward towards
the tumour, and a branch starts forming behind it. As seen in the figure, the tip cell has
moved in a straight line because all the TAF gradient vectors between the initial tip cell’s
location and the tumour are collinear. That is because of the symmetry in the problem.
The bar on the right side defines the value for the phase-field parameter. As seen here, the
parameter is higher on the parent vessel compared to the newly created capillary.
The shape of the parent blood vessel at the junction is the same shape seen in [51].
Note that the transition parameter in the figure is shown in the initial configuration, so
the deformations are not shown here. As seen in the figure, the first jump for the tip cell
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Figure 5.2: The growth of one capillary towards a tumour for model I. This figure shows the
phase-field parameter at the end of the analysis. The maroon rectangle is a tumour. The
white dots show the tip cell path throughout the time which the lowest is the location of
the tip cell at time zero. The bar shows the phase-field parameter, zero is for extracellular
matrix and one is for endothelial cells.
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Figure 5.3: Tip cell load factor and tip cell location evolution throughout the analysis time
for model I.
is longer than other jumps; it is because the tip cell jumped at d = 0.50 at this point while
it jumps at d = dmax = 0.20 at other points. The initial jump can be reduced by closing
the values for dmax and d0 or reducing the value for l and the mesh size.
Tip cell load factor defined in Figure 5.3A is the sum of the loading factors depicted
in Figure 4.2. As seen in 5.3A, the load factor increases until it reaches 1, meaning that
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maximum load is a = 200 kPa, the value defined in Table 5.2, then stays roughly constant
until the end of analysis in the branch. Figure 5.3B shows the closest location of the tip
cell to the tumour, tip cell k in Figure 4.1, with respect to time. The jumps discussed in
Figure 5.2 are seen here too. As discussed before, the first jump which happens in the first
time step is longer and can be seen here at t ≈ 0. The time difference between the jumps
is close to equal which is because the total time is short and the TAF level is low for the
term 1/(1 + βξ) to have any major effects on the active stress produced by 3.44. Figure
5.3C correlates the last tip cell location and the total tip cell load factor. The jags seen
in this plot are similar to those reported in [61]. The aberrations seen in Figure 5.3A and
5.3C can be diminished by reducing the time step size or the element size. The verification
of this model in presented in the next section.
5.4.2 Model II: Stochastic movement of the tip cell
The second model is the same as the first model with the normal distribution turned on
allowing a directed random movement of the tip cells. The normal distribution parameters
are chosen so that the end result of the solver are morphologically consistent with the
results from the earlier analysis done by others.
Figure 5.4 shows the formation of the capillary towards a tumour. Now, the cell did
not go in a straight line to reach the tumour. It also went a little slower than in model I
which is intuitive because the path it is taking the model is a little longer.
Figure 5.5 shows the same information shown in Figure 5.3. Here, the fluctuations in
tip cell load factor are a little larger. This is because the local geometry at the different
tip cell locations constantly changes because of the stochastic movement of the tip cell.
This change in the geometry can make the extracellular matrix less prone to crack at some
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Figure 5.4: The growth of one capillary towards a tumour for model II. This model is
different from the first model in using a normal distribution to find the tip cell location.
points or more prone at some other points.
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Figure 5.5: Tip cell load factor and tip cell location evolution throughout the analysis time
for model II.
5.4.3 Model III: Two tip cells
Unlike previous models, this model has two tip cells initially at the same y-coordinate
as the one in the previous models and the x-coordinates of 0.133 mm and 0.267 mm,
respectively. The tip cell locations are not shown in Figure 5.6 to better see the phase
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transition. As seen in the figure the “straighter” branch, the branch on the left, reached
the tumour slightly sooner than the other branch which is intuitive.
Figure 5.7A shows the tip cell load factor for the branches and same as the previous
models the two branches have fluctuations. Figure 5.7B confirms that the left branch is
slightly faster than the right branch.
Comparing this model with model II, it can be inferred that the speed of the endothelial
cells migration is about the same in the two models. As mentioned in chapter three,
equation 3.41, e−b(‖r‖−r0)
2
defines the magnitude of the active stress exerted by the tip cells
on the extracellular matrix. With the parameters defined in Table 5.2, the effective range
of the active stress is 27 µm. The effective range is defined here as the range that active
stress is more than 10% of its maximum value. It is intuitive that to have two active stress
fields affecting each other, their distance, the distance of their centers, should be at most
summation of the two effective ranges. The distance of the two tip cells in this model is
134 µm which is more than twice the effective range of the tip cells, 54 µm, so the two tip
cells effect on each other is negligible. The distance between the two tip cells is why model
I and model II tip cells have the same speed.
Decreasing the distance between the two tip cells will result in the two stress fields
affecting resulting in tip cells migrating faster. This phenomenon also occurs in the next
model, as at some points, the tip cells for different branches are closer to each other than
the effective range. The effect of this will be discussed in the next subsection.
5.4.4 Model IV: Stochastic movement with branching
This model is the same as the second model, but the branching engine is turned on in this
model. Because of the random nature of branching, some constraints are set in the branch-
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Figure 5.6: The growth of one capillary towards a tumour for model III. This model is
different from the second model by having two tip cells initially.
ing engine to improve the model’s operation. Similar approach was applied in literature as
seen in [64]. First, no branching would happen in y < 0.12 mm. When a branch appears
in a location, no more branches can occur in the next eight tip cell locations. Moreover,
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Figure 5.7: Tip cell load factor and tip cell location evolution throughout the analysis time
for model III. The two plot colours stand for the two different branches shown in 5.6.
the first tip cell of the new branch will be in the normal direction of the current vessel.
The first two assumptions are made so that the branching would not be affected by the
transition diffusion depth, parameter l, of the other capillaries. Decreasing the element
size and the length-scale parameter will ease the constraints.
Running the simulations with the above constraints results in Figure 5.8. The first
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Figure 5.8: The growth of one capillary towards a tumour for model IV. This model is
different from the second model by turning the branching engine on.
branch initiated at t = 0.51 days and followed by the second one at t = 1.01 days. As
mentioned before, in this model the tip cells are closer to each other than as seen in model
III. At the time that the first branching occurs, the distance between the two tip cells is
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Figure 5.9: Relationship between the distance between the two tip cells right after the first
branching occurs and the velocity of migration of the main branch.
53.9 µm. As shown in Figure 5.9A, this distance increases initially and then decreases but
stays over the effective range, 54 µm, for the first 24.5 hours of the simulation. The decrease
continues to the degree that at t = 30.7 h the distance between the two tip cells reaches
6.94 µm. The stress fields of the adjacent tip cells result in bigger local deformations and
higher potential energy. This results in the energy-based crack criterion being met sooner
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and finally in a faster migration towards the tumour. Figure 5.9B is the evidence for this
increase in migration speed. This is the greatest significance of this modelling approach.
It shows the role of the mechanical properties and the mechanical fields on the progress of
angiogenesis.
5.5 Verification
Comprehensive verification of this model is a challenge because of the type of outputs pro-
duced by the model. These outputs include the displacement and stress fields in addition
to the phase-change variable (i.e. changing of the ECM to the EC lining the blood vessels).
Due to the difficulties associated with experimental measurement, little attention has been
paid in literature to measure these parameters as extensive as shown here. Therefore, lim-
ited verification was conducted and focused on some defining outputs which are extracted
and compared to available experimental data.
The two defining outputs are the width of the capillaries and speed of the endothelial
cells migration. The newly-formed capillaries have the width of about 10 µm which is
represented by the yellow zone in branches in figures such as in Figure 5.7. This width is
close to the average capillary width [19] of around 9 µm. The measured speed of tip cells
migration in the proposed model is about 7.5 µm/hr. This is acquired by determining the
average speed of the endothelial cells migration throughout the entire time frame of the
model which is close to 6.0 µm/hr proposed in [26] and is in the range suggested in the
mathematical models by Zaman and DiMilla [87, 88] and the experimental data in [89].
Other characteristics like the direction of the endothelial cells movement and the oc-
currence of branching can be modified easily by changing their respected parameters in the
vascular network module and are not discussed here.
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5.6 Conclusion
This chapter started with acquiring most of the parameters’ values from the literature and
setting the rest by calibrating the model with respect to the results in the model proposed
by McDougall [26]. Then, initial and boundary conditions were set, and a domain was
defined to run the analysis. Four different simulations as shown by Table 5.4 were run,
and the results were discussed. Each of the four simulations became more detailed and
added new aspects of angiogenesis. The experimental observations verified the model by
comparing the defining characteristics seen in vitro with the output of the in silico model.
These defining characteristics are the vessel width and the migration speed of the tip cells
and were found compatible with the experimental observations.
Overall, this chapter shows the stability of the model proposed here and the power it
holds.
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Chapter 6
Conclusion & Future Works
6.1 Conclusion
Some in silico tumour-induced angiogenesis models are proposed every year. Each of these
models tries to focus and capture distinct aspects of the complex phenomenon [90, 91]. The
core of the model developed in this research is the mechanical aspect of the propagation of
the endothelial cells in the extracellular matrix. This work models the matrical pathways
in angiogenesis with fracture mechanics formulation. This formation of matrix pathways in
the ECM is assumed to be equivalent to the migration of the ECs. A modular solver with
three modules is the backbone of this research with each module accounting for one aspect
of the phenomenon. One of the novelties in this solver is the integration of ductile fracture
mechanics in the phase-field equation. This innovation is based on the crack phase-field
equations proposed in [92, 3]. Unlike the hybrid models in the literature, the continuum and
discrete components here are more interrelated than the models which extract a velocity
function from the continuum component for the movement of the tip cell. The solver
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implements finite element method to solve the PDEs present in the continuum component.
Several numerical simulations presented here prove the stability and reliability of the
framework. Yet, there is a need for a better calibration of the parameters given in tables
5.1, 5.2, and 5.3 with more experimental data. Also, further improvement of the model
can result in a better understanding of the processes in tumour progression with a po-
tential contribution to new treatments for cancer, as mentioned in the next section. The
treatments in mind here are solid mechanics related. An example of this is increasing the
energy needed for the fracture of the extracellular matrix or make it more resistant to the
MDEs so that the ECM averts the progression of angiogenesis.
6.2 Future Works
The experimental data on angiogenesis is still minimal but yet, a lot of theoretical im-
provements can be added to the solver presented in this work to make the model more
comprehensive and more realistic. The list of improvements is as follows:
• Branching and anastomosis are the first two essential phenomena that need to be
improved in the modelling. Most of the algorithms found in the literature purely rely
on experimental works with no good theories existing on these matters yet.
• Incorporating higher-order phase-field function [71] like the one discussed in 3.27; for
numerical implementation there is need for using either higher-order finite element
[93, 94], i.e. Hermite shape functions, or isogeometric analysis for providing H2 space
using C1 shape functions.
• Isogeometric Analysis [70, 95] is the only computational feasible way to produce C1
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shape functions in a three-dimensional space. It can help better integrate the geom-
etry with no significant increase in computational cost. Incorporating isogeometric
analysis in future modellings instead of conventional finite elements can facilitate the
usage of higher-order phase-field functions.
• Better degradation functions for better modelling of the softening behaviour asso-
ciated with the mechanical aspect of phase transition. Many experiments need to
be performed to find the best degradation function such as the cubic degradation
function as seen in 3.48 [81, 61].
• The cells life cycles can be modelled by modelling mitosis, apoptosis, and necrosis
in the endothelial cells [48]. The last term in 3.77 is an example of the modelling of
mitosis.
• More parameters can be used to construct multiphase-field model[96]. The phase-
field parameter defined in this work showed the interface between the endothelial
cells and the extracellular matrix. The new parameters can model other phases such
as the lumen.
• Porous material properties for the ECM can be applied. Also, fluid mechanics and
solid-fluid interaction can be added for modelling the blood flow using [92, 97].
• The force exerted on the matrix for the migration process needs some more extensive
experimental work to develop better equations.
• Agent-based modelling can be introduced to model the discrete parts of the problem
[64, 98] in the vascular network module.
• Cellular potts approach can be used instead of phase-field approach which integrates
the cells individually [99].
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